Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000090630

Apexbio Technology LLC Glycyrrhizic acid 1405-86-3 20mg
SDP

Catalog No. 5000090630
Encompass_Preferred

Glycyrrhizic acid (CAS 1405-86-3) is a triterpenoid saponin antagonist targeting high mobility group box 1 (HMGB1) and inhibitor of monoamine oxidase (MAO) as well as cytochrome P450 enzymes (CYP3A4 CYP2C9 CYP2C19) and 11 -hydroxysteroid dehydrogenase type 2 (11 -HSD2) It is designed to antagonize HMGB1-mediated pro-inflammatory responses and oxidative stress inhibit the enzymatic activity of MAO and 11 -HSD2 and modulate cytochrome P450-mediated metabolism Glycyrrhizic acid exerts its biological activity primarily through competitive inhibition of these enzymes It demonstrates MAO inhibition with an IC50 of approximately 0 16 M and competitively inhibits CYP3A4 (IC50 8 2 M) CYP2C9 ( 42 9 M) and CYP2C19 ( 40 3 M) Based on these pharmacological properties glycyrrhizic acid holds research potential in anti-inflammatory pathways enzyme inhibition and glucose metabolic modulation

Catalog No. 50-000-90630 Supplier Apexbio Technology LLC Supplier No. N179220
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Glycyrrhizic acid (CAS 1405-86-3) is a triterpenoid saponin antagonist targeting high mobility group box 1 (HMGB1) and inhibitor of monoamine oxidase (MAO) as well as cytochrome P450 enzymes (CYP3A4 CYP2C9 CYP2C19) and 11 -hydroxysteroid dehydrogenase type 2 (11 -HSD2) It is designed to antagonize HMGB1-mediated pro-inflammatory responses and oxidative stress inhibit the enzymatic activity of MAO and 11 -HSD2 and modulate cytochrome P450-mediated metabolism Glycyrrhizic acid exerts its biological activity primarily through competitive inhibition of these enzymes It demonstrates MAO inhibition with an IC50 of approximately 0 16 M and competitively inhibits CYP3A4 (IC50 8 2 M) CYP2C9 ( 42 9 M) and CYP2C19 ( 40 3 M) Based on these pharmacological properties glycyrrhizic acid holds research potential in anti-inflammatory pathways enzyme inhibition and glucose metabolic modulation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.